159 related articles for article (PubMed ID: 12782944)
1. Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA).
Whitehouse PA; Knight LA; Di Nicolantonio F; Mercer SJ; Sharma S; Cree IA;
Anticancer Drugs; 2003 Jun; 14(5):369-75. PubMed ID: 12782944
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of chemosensitivity of metastatic cutaneous melanoma.
Cree IA; Neale MH; Myatt NE; de Takats PG; Hall P; Grant J; Kurbacher CM; Reinhold U; Neuber K; MacKie RM; Chana J; Weaver PC; Khoury GG; Sartori C; Andreotti PE
Anticancer Drugs; 1999 Jun; 10(5):437-44. PubMed ID: 10477162
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of chemosensitivity of esophageal and gastric carcinoma.
Mercer SJ; Somers SS; Knight LA; Whitehouse PA; Sharma S; Di Nicolantonio F; Glaysher S; Toh S; Cree IA;
Anticancer Drugs; 2003 Jul; 14(6):397-403. PubMed ID: 12853879
[TBL] [Abstract][Full Text] [Related]
4. In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA).
Cho YB; Lee WY; Song SY; Choi SH; Shin HJ; Ahn KD; Lee JM; Kim HC; Yun SH; Chun HK
Eur J Surg Oncol; 2009 Sep; 35(9):951-6. PubMed ID: 19181477
[TBL] [Abstract][Full Text] [Related]
5. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of adenosine triphosphate-based chemotherapy response assay in colorectal cancer--secondary publication.
Huh JW; Park YA; Lee KY; Sohn SK
Yonsei Med J; 2009 Oct; 50(5):697-703. PubMed ID: 19881975
[TBL] [Abstract][Full Text] [Related]
7. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of P-glycoprotein, glutathione S-transferase-pi and thymidylate synthase proteins and adenosine triphosphate tumor chemosensitivity assay in cervical cancer].
Gao GL; Wan HY; Zou XS; Chen WX; Chen YQ; Huang XZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):201-5. PubMed ID: 17537309
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay.
Ling ZQ; Qi CJ; Lu XX; Qian LJ; Gu LH; Zheng ZG; Zhao Q; Wang S; Fang XH; Yang ZX; Yin J; Mao WM
Acta Pharmacol Sin; 2012 Mar; 33(3):401-6. PubMed ID: 22286916
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitivity testing in malignant melanoma.
Ugurel S; Tilgen W; Reinhold U
Recent Results Cancer Res; 2003; 161():81-92. PubMed ID: 12528801
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer.
Kwon HY; Kim IK; Kang J; Sohn SK; Lee KY
Cancer Res Treat; 2016 Jul; 48(3):970-7. PubMed ID: 26511802
[TBL] [Abstract][Full Text] [Related]
14. The ex vivo chemosensitivity profile of choroidal melanoma.
Myatt N; Cree IA; Kurbacher CM; Foss AJ; Hungerford JL; Plowman PN
Anticancer Drugs; 1997 Sep; 8(8):756-62. PubMed ID: 9396619
[TBL] [Abstract][Full Text] [Related]
15. ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials.
Kurbacher CM; Grecu OM; Stier U; Gilster TJ; Janát MM; Untch M; Konecny G; Bruckner HW; Cree IA
Recent Results Cancer Res; 2003; 161():221-30. PubMed ID: 12528810
[TBL] [Abstract][Full Text] [Related]
16. In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
Yamashita K; Urakami A; Kubozoe T; Ikeda M; Hirabayashi Y; Yamamura M; Iki K; Akiyama T; Matsumoto H; Hirai T; Sadahira Y; Tsunoda T
Int J Clin Oncol; 2005 Oct; 10(5):328-32. PubMed ID: 16247659
[TBL] [Abstract][Full Text] [Related]
17. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.
Neale MH; Myatt NE; Khoury GG; Weaver P; Lamont A; Hungerford JL; Kurbacher CM; Hall P; Corrie PG; Cree IA
Melanoma Res; 2001 Dec; 11(6):601-9. PubMed ID: 11725206
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
